Fanshawe College is a community college providing post-secondary education, skills training and upgrading to more than 45,500 full-time and part-time students in Elgin, Middlesex, Norfolk, Oxford and Huron-Perth counties. The College has an annual operating budget of approximately $330 million and over 3,000 employees.
The Board of Governors of Fanshawe College is seeking applications for membership to fill three vacancies on the Board commencing September 1, 2021.
The Board sets the Vision and Mission of the College and develops and monitors policies to ensure Fanshawe College fulfills these important aspirations. The Board governs in constructive partnership with the President in pursuit of the Mission. Members of the Board are volunteers who serve without remuneration for up to two, three-year terms of office.
An individual with knowledge and expertise in any of the following skills is an asset: education, finance, IT and cybersecurity or the skilled trades. Experience in policy governance, competitive strategies and regulatory environments is also welcome.
If you are interested in serving as a member of the Fanshawe College Board of Governors, please submit your letter of application, along with your curriculum vitae to the Board of Governor’s Office by email to BoardofGovernors@fanshawec.ca or by mail:
Board of Governor’s Office, Fanshawe College
1001 Fanshawe College Boulevard, Room H1004
P.O. Box 7005
London, ON, N5Y 5R6
Fanshawe College is an equal opportunity employer. We are committed to equity, value diversity, and encourage applicants from diverse backgrounds. Fanshawe provides accommodations to applicants with disabilities in accordance with the Access for Ontarians with Disabilities Act (AODA).
The deadline for submission is October 30, 2020.
- The Fanshawe College 2020 United Way campaign kicked off October 8, 2020 and will run until the end of January 2021.
- Fanshawe College’s Centre for Research and Innovation has developed a safe, rapid and inexpensive method to identify the effectiveness of potential COVID-19 drug treatments.